OPCH Option Care Health, Inc. - Common Stock

Option Care Health (OPCH) is back in focus after fresh commentary compared its home and alternate site infusion business with BrightSpring Health Services, highlighting how both could benefit as complex treatments continue shifting into lower cost home settings. Recent trading tells a mixed story. Option Care Health’s share price is up 8.41% over the past 90 days but down 29.25% year to date, while the 1 year total shareholder return has declined 17.83%, which may hint at fading momentum...

BrightSpring's faster growth, pharmacy and provider-service expansion, and improving margins contrast with OPCH's slower growth and chronic-therapy pressures.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 38.9% over the past six months, topping the S&P 500 by 20.9 percentage points.

Over the last six months, Option Care Health’s shares have sunk to $23.95, producing a disappointing 15.7% loss - a stark contrast to the S&P 500’s 16.2% gain. This might have investors contemplating their next move.

BrightSpring Health Services has surged 54% YTD on specialty pharmacy, infusion and EBITDA growth, but premium valuation and policy headwinds remain.

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

BrightSpring Health Services is gaining acute infusion share with 20%+ volume growth, targeting 12-15 new states in a $20 billion market.

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the senior health, home health & hospice stocks, including Option Care Health (NASDAQ:OPCH) and its peers.

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.

Option Care Health stock has had a difficult few years, yet the current valuation checks do not all point in the same direction. The intrinsic value estimate using a Discounted Cash Flow model suggests the shares trade at a premium to that model, while market based multiples look more supportive. Over the past 3 years the share price has declined 32.2%, which puts extra focus on whether the current level already reflects the weaker shareholder returns. Future profitability and cash flow from...

Outpatient and home healthcare stocks gain from aging, digital care and AI, with LifeStance, Option Care, Aveanna and DaVita in focus.

An aging population and growing telehealth and AI adoption support the Zacks Medical - Outpatient and Home Healthcare industry. DVA, LFST, OPCH and AVAH stand to benefit.

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

OPCH vs. CHE: Which Stock Is the Better Value Option?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

CID census stabilizes as facility-based nursing expands and AI tools drive operational efficiency.

OPCH vs. PNTG: Which Stock Is the Better Value Option?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

BrightSpring beat second-quarter estimates and raised its 2026 outlook as specialty, infusion and home health growth lifted margins and EBITDA.

BrightSpring's broad-based growth and margin gains strengthen its outlook, but a premium valuation leaves little room for execution missteps.

Alternate site health provider Option Care Health (NASDAQ:OPCH) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 1.9% year on year to $1.44 billion. The company expects the full year’s revenue to be around $5.73 billion, close to analysts’ estimates. Its non-GAAP profit of $0.45 per share was 5.4% above analysts’ consensus estimates.

Option Care Health (OPCH) is back in focus after releasing second quarter 2026 results and updating earnings guidance for the rest of the year. Investors now have fresh numbers to assess the stock. See our latest analysis for Option Care Health. The latest earnings and guidance appear to have sparked shorter term interest in Option Care Health, with a 7.06% 30 day share price return and 12.08% 90 day share price return. However, the share price is still down 30.37% year to date and the 1 year...

Option Care Health Inc (OPCH) reports robust financial performance with significant advancements in strategic initiatives and facility expansions.

Moby summary of Option Care Health, Inc.'s Q2 2026 earnings call

Option Care Health (NASDAQ:OPCH) reported second-quarter 2026 results that exceeded its internal expectations, with revenue, adjusted EBITDA and adjusted earnings per share all improving sequentially. The home and alternate-site infusion provider maintained its full-year revenue outlook while narrow

Option Care (OPCH) delivered earnings and revenue surprises of +7.14% and +1.68%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Alternate site health provider Option Care Health (NASDAQ:OPCH) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 1.9% year on year to $1.44 billion. The company expects the full year’s revenue to be around $5.73 billion, close to analysts’ estimates. Its non-GAAP profit of $0.45 per share was 5.4% above analysts’ consensus estimates.

Alternate site health provider Option Care Health (NASDAQ:OPCH) will be announcing earnings results this Wednesday morning. Here’s what to look for.

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 10.2% over the past six months while the S&P 500 was up 7.7%.

Madison Small Cap Fund, managed by Madison Funds, released its Q2 2026 investor letter. A copy of the letter can be downloaded here. The small-cap market showed exceptional strength in Q2, largely due to anticipated peace in the Middle East. The Russell 2000 Index began to rally, propelled by Information Technology, Health Care, and Industrials. The […]

Apple upgraded, Brinker initiated: Wall Street's top analyst calls